For a patient using a compression bandage, ice, and elevation who takes mefenamic acid as needed for pain, what is the appropriate dosing regimen and when should celecoxib be initiated for breakthrough pain?

NSAID Management for Acute Musculoskeletal Pain

For your current regimen using compression, ice, elevation and PRN mefenamic acid, continue mefenamic acid 500 mg initial dose followed by 250 mg every 6 hours as needed (not exceeding 1 week), and switch to celecoxib 400 mg loading dose followed by 200 mg twice daily if pain persists beyond 24-48 hours or is inadequately controlled. 1

Mefenamic Acid Dosing

Your current approach with mefenamic acid is appropriate for initial pain management:

• Initial dose: 500 mg
• Maintenance: 250 mg every 6 hours as needed
• Maximum duration: 1 week (typically not necessary beyond this timeframe) 1

Mefenamic acid provides effective analgesia for acute pain with a favorable safety profile when used short-term 2. The evidence shows it works well for acute musculoskeletal conditions, though data specifically for ankle sprains is limited.

When to Switch to Celecoxib

Switch to celecoxib if:

• Pain remains moderate to severe after 24-48 hours of mefenamic acid
• You need more sustained pain relief (celecoxib provides longer duration of action)
• You require treatment beyond 1 week

Celecoxib Dosing Regimen

For acute pain:

• Loading dose: 400 mg on Day 1 (can give 400 mg initially, then 200 mg later same day)
• Maintenance: 200 mg twice daily for subsequent days 3, 4

This dosing provides rapid onset (median 28 minutes) and sustained pain relief superior to lower doses 4. In acute ankle sprain specifically, celecoxib 400 mg/day demonstrated significant pain reduction with patients recovering faster (5 days) compared to placebo (8 days) 5.

Important Context on RICE and NSAIDs

Critical caveat: The 2018 British Journal of Sports Medicine guideline found no evidence that RICE alone has positive influence on pain, swelling or patient function in acute ankle sprains 6. However, cryotherapy combined with exercise therapy does show benefit. Your compression bandage, ice, and elevation are reasonable supportive measures but should not be relied upon as primary treatment.

NSAID Efficacy Evidence

Both oral NSAIDs (including mefenamic acid and celecoxib) provide:

• Significant short-term pain reduction (<14 days) 6
• Celecoxib 400 mg shows comparable efficacy to ibuprofen 400 mg and superior duration of action 4
• Celecoxib demonstrates non-inferiority to non-selective NSAIDs for acute pain 6

Safety Considerations

Mefenamic acid: Well-tolerated for short-term use (≤7 days), minimal serious adverse events in acute pain studies 2

Celecoxib:

• Better GI tolerability than traditional NSAIDs (approximately 50% reduction in GI complications) 7
• Comparable cardiovascular safety to other NSAIDs at therapeutic doses 7
• Consider adding proton pump inhibitor if you have GI risk factors (age >65, previous GI events, concurrent anticoagulation/corticosteroids) 7

Practical Algorithm

1. Days 1-2: Mefenamic acid 500 mg loading, then 250 mg q6h PRN + supportive measures
2. Assess at 24-48 hours:
   • If pain improving → continue mefenamic acid (max 7 days total)
   • If pain moderate-severe or inadequate relief → switch to celecoxib 400 mg loading dose
3. Days 3-7: Celecoxib 200 mg BID if switched
4. Beyond 7 days: Re-evaluate; if still requiring NSAIDs, celecoxib 200 mg daily or BID is appropriate for longer-term use 3

Key pitfall to avoid: NSAIDs may theoretically delay natural healing by suppressing inflammation necessary for tissue recovery 6. Use the lowest effective dose for the shortest duration needed for adequate pain control.